Pursuant To Merger Agreement Terms, Concentra Merger Sub II And Theseus Determine Additional Price Per Share Max Of $0.15/Share; Cash Amount Paid In Offer Is $4.05/Share
As previously announced on December 22, 2023, Concentra Biosciences, LLC ("Parent") and its wholly owned subsidiary, Concentra Merger Sub II, Inc. ("Purchaser"), entered into a merger agreement (the "Merger Agreement")